Related Experiment Video
Updated: May 16, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
miRNAs, polyphenols, and chronic disease.
Cinta Bladé1, Laura Baselga-Escudero, Maria Josepa Salvadó
1Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain. mariacinta.blade@urv.cat
Molecular Nutrition & Food Research
|November 21, 2012
Summary
Polyphenols, natural compounds found in plants, can regulate microRNAs (miRNAs) involved in metabolic health and chronic diseases. Further research is needed to identify and confirm more polyphenol-miRNA interactions for therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression posttranscriptionally.
- miRNAs are implicated in metabolic homeostasis and the pathogenesis of chronic diseases.
- Polyphenols are plant-derived compounds with potential health benefits.
Purpose of the Study:
- To explore the role of polyphenols in modulating miRNA expression.
- To investigate the potential of polyphenol-miRNA interactions in managing metabolic diseases.
- To highlight the need for further research into specific polyphenol-miRNA targets.
Main Methods:
- Literature review of studies investigating polyphenol-miRNA interactions.
- Analysis of existing data on miRNA regulation by polyphenols.
- Identification of specific miRNAs modulated by polyphenols, e.g., miR-122.
Main Results:
- Polyphenols demonstrate the ability to modulate miRNAs associated with metabolic regulation.
- This modulation affects gene expression at the posttranscriptional level.
- Evidence suggests polyphenols can target specific miRNAs, such as miR-122.
Conclusions:
- Polyphenolic modulation of miRNAs presents a promising therapeutic strategy for chronic diseases.
- Targeting specific miRNAs with polyphenols could offer a novel approach to disease management.
- More research is required to discover and validate additional polyphenol-miRNA interactions.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...